Observational Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1272-1279
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1272
Table 1 Clinical parameters of patients with healthy subjects, type 2 diabetes mellitus patients and type 2 diabetes mellitus patients with hypertension
Clinical parameters
Healthy subjects (n = 101)
T2DM (n = 97)
T2DM + HP (n = 70)
P value
Age, yr48.06 ± 9.9049.04 ± 12.8052.00 ± 11.500.068
Male, n (%)48 (48)61 (63)39 (56)0.094
Hight, cm165.10 ± 7.50166.87 ± 9.25164.66 ± 7.530.199
Wight, kg64.14 ± 10.5872.50 ± 15.34172.23 ± 13.801< 0.001
BMI, kg/m223.44 ± 2.8425.85 ± 3.90126.51 ± 4.021< 0.001
BSA, m21.68 ± 0.171.79 ± 0.2411.78 ± 0.211< 0.001
SBP, mmHg123.26 ± 10.82127.65 ± 14.701137.07 ± 17.341,2< 0.001
DBP, mmHg77.85 ± 7.6579.25 ± 10.5986.64 ± 10.201,2< 0.001
HR, bpm69.85 ± 9.7675.22 ± 9.60179.10 ± 12.721,2<0.001
FPG, mmol/L4.95 (4.59, 5.25)10.53 (7.87, 14.07)18.91 (7.57, 10.97)1< 0.001
HbA1c, %5.45 ± 0.389.73 ± 2.2718.85 ± 2.491,2< 0.001
TC, mmol/L4.54 ± 0.854.37 ± 0.904.70 ± 1.140.102
TG, mmol/L1.21 (0.88,1.78)1.53 (0.97, 2.15)12.00 (1.38, 2.83)1,2< 0.001
HDL-C, mmol/L1.27 ± 0.301.09 ± 0.2911.04 ± 0.281< 0.001
LDL-C, mmol/L2.68 ± 0.702.65 ± 0.792.81 ± 0.990.556
LPA, g/L0.17 (0.11, 0.28)0.14 (0.06, 0.24)0.14 (0.08, 0.25)0.231
BUN, mmol/L4.75 (3.60, 5.70)5.50 (4.60, 6.30)15.50 (4.50, 7.40)10.001
SCR, μmol/L61.00 (55.00, 76.00)59.00 (49.30, 71.10)64.00 (54.00, 87.00)20.030
Medication, n (%)
    ACEI/ARB--32 (46)
    Calcium channel blocker--37 (53)
    β-blocker--4 (6)
    SGLT-2 inhibitor-18 (19)28 (40)
    Metformin-59 (61)38 (54)
    Insulin-55 (57)35 (50)